Teachers Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Teachers Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.78M	Buy	133,769 +7,865	+6%	+$83.6K	﹤0.01%	2021
2018 Q4	$991K	Buy	125,904 +1,496	+1%	+$14.2K	﹤0.01%	2193
2018 Q3	$1.38M	Buy	124,408 +11,660	+10%	+$145K	﹤0.01%	2161
2018 Q2	$1.51M	Buy	+112,748	New	+$1.41M	﹤0.01%	2118

Other funds holding CBAY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Teachers Advisors's CBAY Position: Q1 2019 in Review

Teachers Advisors increased its Cymabay Therapeutics (CBAY) stake by 6.2% in Q1 2019, buying an estimated $83.6K and bringing the position to 133,769 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2021.

Teachers Advisors first reported a position in CBAY in Q2 2018 and has held it in 4 quarters since. 142 funds tracked by Wall St. Rank hold CBAY as of Q1 2019.

Teachers Advisors held 133,769 shares of Cymabay Therapeutics worth $1.78M as of Q1 2019.
Teachers Advisors bought 7,865 Cymabay Therapeutics shares in Q1 2019, an estimated $83.6K.
Cymabay Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2021 holding.
Teachers Advisors first reported a position in Cymabay Therapeutics in Q2 2018 and has held it in 4 quarters since.
142 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.